Search results
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5...
Benzinga via Yahoo Finance· 11 months agoIn an annual general meeting, BioNTech SE's (NASDAQ: BNTX) CEO and co-founder Ugur Sahin told...
BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots
Benzinga via Yahoo Finance· 1 year agoBioNTech SE (NASDAQ: BNTX) has reported Q3 FY22 revenues of €3.46 billion, down from €6.09 billion a...
Insiders own 20% of BioNTech SE (NASDAQ:BNTX) shares but private equity firms control 44% of the...
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights The considerable ownership by private equity firms in BioNTech indicates that they...
BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while...
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
BioNTech SE's (NASDAQ:BNTX) largest shareholders are private equity firms with 44% ownership,...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights The considerable ownership by private equity firms in BioNTech indicates that they...
BioNTech SE's (NASDAQ:BNTX) market cap surged US$4.0b last week, private equity firms who have a lot...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls BioNTech SE (NASDAQ:BNTX), then you'll have to look at the...
BioNTech SE (NASDAQ:BNTX) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 months agoBioNTech SE (NASDAQ:BNTX) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Welcome to...
As Covid-19 shot sales dwindle, BioNTech doubles down on cancer vaccines
Quartz via Yahoo Finance· 1 year agoBioNTech is over covid. Or looking past it, at least, planning to invest the company’s pandemic...
Pfizer, BioNTech launch phase 1 trial on combined COVID-19 and flu vaccine
ABC News via Yahoo News· 2 years agoPfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and...
BioNTech predicts return to revenue growth in 2025
Reuters via Yahoo Finance· 4 months ago(Reuters) -BioNTech said on Tuesday it expects to return to revenue growth in 2025 when the ongoing decline in its COVID-19 vaccine business would bottom...